Tag Archives: Autoimmune

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Posted on September 19, 2019 by

Recent studies indicate that higher strength disease modifying therapies (DMTs) may slow disability progression in secondary progressive multiple sclerosis (MS), as well as reduce the number of relapses. There have also been trials in primary progressive MS but these, most … Continue reading →

Posted in Inflammatory/ Auto-Immune Diseases | Tagged , , , , | 1 Comment

Thymectomy for Myasthenia Gravis

Posted on November 24, 2016 by

  Introduction While thymectomy has long been considered an option to treat myasthenia even if there is simply thymic tissue present rather than thymoma or thymic carcinoma, it has been uncertain how much benefit is achieved by undergoing this major … Continue reading →

Posted in Myasthenia | Tagged , , , | Leave a comment

Anti K+ Channel Antibodies in Neuromyotonia

Posted on June 7, 2016 by

Background At this Journal Club it was decided to review a historical paper on the pathophysiology underlying autoimmune neuromyotonia. The paper, “Autoantibodies Detected to Expressed K+ Channels Are Implicated in Neuromyotonia”, from Annals of Neurology (1997, 41:238-246), used a novel … Continue reading →

Posted in Inflammatory/ Auto-Immune Diseases | Tagged , , , | Leave a comment